Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Comment by Xcal911on May 28, 2010 2:43pm

341 Views

Post# 17140998

RE: L2 anyone

Level 2 Quote

Market Maker	Shares	Bid Price	Ask Price	Shares	Market Maker
--	488,000	0.085	0.090	522,000	--
--	804,000	0.080	0.095	570,000	--
--	859,000	0.075	0.100	604,000	--
--	1,914,000	0.070	0.105	43,000	--
--	413,000	0.065	0.110	167,000	--
--	1,031,000	0.060	0.115	70,000	--
--	387,000	0.055	0.120	390,000	--
--	1,014,000	0.050	0.125	74,000	--
--	--	--	0.130	40,000	--
--	--	--	0.135	13,000	--